|
1
|
Porter S, Clark IM, Kevorkian L and
Edwards DR: The ADAMTS metalloproteinases. Biochem J. 386:15–27.
2005. View Article : Google Scholar :
|
|
2
|
Tang BL and Hong W: ADAMTS: a novel family
of proteases with an ADAM protease domain and thrombospondin 1
repeats. FEBS Lett. 445:223–225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaushal GP and Shah SV: The new kids on
the block: ADAMTSs, potentially multifunctional metalloproteinases
of the ADAM family. J Clin Invest. 105:1335–1337. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colige A, Sieron AL, Li SW, et al: Human
Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are
caused by mutations in the procollagen I N-proteinase gene. Am J
Hum Genet. 65:308–317. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levy GG, Nichols WC, Lian EC, et al:
Mutations in a member of the ADAMTS gene family cause thrombotic
thrombocytopenic purpura. Nature. 413:488–494. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dunn JR, Panutsopulos D, Shaw MW, et al:
METH-2 silencing and promoter hypermethylation in NSCLC. Br J
Cancer. 91:1149–1154. 2004.PubMed/NCBI
|
|
7
|
Glasson SS, Askew R, Sheppard B, et al:
Characterization of and osteoarthritis susceptibility in
ADAMTS-4-knockout mice. Arthritis Rheum. 50:2547–2558. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Porter S, Scott SD, Sassoon EM, et al:
Dysregulated expression of adamalysin-thrombospondin genes in human
breast carcinoma. Clin Cancer Res. 10:2429–2440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Llamazares M, Obaya AJ, Moncada-Pazos A,
et al: The ADAMTS12 metalloproteinase exhibits anti-tumorigenic
properties through modulation of the Ras-dependent ERK signalling
pathway. J Cell Sci. 120:3544–3552. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Keightley MC, Sales KJ and Jabbour HN:
PGF2alpha-F-prostanoid receptor signalling via ADAMTS1 modulates
epithelial cell invasion and endothelial cell function in
endometrial cancer. BMC Cancer. 10:4882010. View Article : Google Scholar
|
|
11
|
Mochizuki S and Okada Y: ADAMs in cancer
cell proliferation and progression. Cancer Sci. 98:621–628. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones GC and Riley GP: ADAMTS proteinases:
a multi-domain, multi-functional family with roles in extracellular
matrix turnover and arthritis. Arthritis Res Ther. 7:160–169. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sandy JD, Westling J, Kenagy RD, et al:
Versican V1 proteolysis in human aorta in vivo occurs at the
Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1
and ADAMTS-4. J Biol Chem. 276:13372–13378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Russell DL, Doyle KM, Ochsner SA, Sandy JD
and Richards JS: Processing and localization of ADAMTS-1 and
proteolytic cleavage of versican during cumulus matrix expansion
and ovulation. J Biol Chem. 278:42330–42339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuno K, Bannai K, Hakozaki M, Matsushima K
and Hirose K: The carboxyl-terminal half region of ADAMTS-1
suppresses both tumorigenicity and experimental tumor metastatic
potential. Biochem Biophys Res Commun. 319:1327–1333. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Obika M, Ogawa H, Takahashi K, et al:
Tumor growth inhibitory effect of ADAMTS1 is accompanied by the
inhibition of tumor angiogenesis. Cancer Sci. 103:1889–1897. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luque A, Carpizo DR and Iruela-Arispe ML:
ADAMTS1/METH1 inhibits endothelial cell proliferation by direct
binding and sequestration of VEGF165. J Biol Chem. 278:23656–23665.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gustavsson H, Wang W, Jennbacken K, Welen
K and Damber JE: ADAMTS1, a putative anti-angiogenic factor, is
decreased in human prostate cancer. BJU Int. 104:1786–1790. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Freitas VM, do AJB, Silva TA, et al:
Decreased expression of ADAMTS-1 in human breast tumors stimulates
migration and invasion. Mol Cancer. 12:22013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martino-Echarri E, Fernandez-Rodriguez R,
Rodriguez-Baena FJ, et al: Contribution of ADAMTS1 as a tumor
suppressor gene in human breast carcinoma. Linking its tumor
inhibitory properties to its proteolytic activity on nidogen-1 and
nidogen-2. Int J Cancer. 133:2315–2324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toyota M, Ahuja N, Suzuki H, et al:
Aberrant methylation in gastric cancer associated with the CpG
island methylator phenotype. Cancer Res. 59:5438–5442.
1999.PubMed/NCBI
|
|
22
|
Chen J, Zhi Y, Chang X, Zhang S and Dai D:
Expression of ADAMTS1 and its correlation with angiogenesis in
primary gastric cancer and lymph node metastasis. Dig Dis Sci.
58:405–413. 2013. View Article : Google Scholar
|
|
23
|
Zhi Y, Chen J, Zhang S, Chang X, Ma J and
Dai D: Downregulation of CXCL12 by DNA hypermethylation and its
involvement in gastric cancer metastatic progression. Dig Dis Sci.
57:650–659. 2012. View Article : Google Scholar
|
|
24
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi JE, Kim DS, Kim EJ, et al: Aberrant
methylation of ADAMTS1 in non-small cell lung cancer. Cancer Genet
Cytogenet. 187:80–84. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee NV, Sato M, Annis DS, et al: ADAMTS1
mediates the release of antiangiogenic polypeptides from TSP1 and
2. EMBO J. 25:5270–5283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Masui T, Hosotani R, Tsuji S, et al:
Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer
Res. 7:3437–3443. 2001.PubMed/NCBI
|
|
28
|
Ahlquist T, Lind GE, Costa VL, et al: Gene
methylation profiles of normal mucosa and benign and malignant
colorectal tumors identify early onset markers. Mol Cancer.
7:942008. View Article : Google Scholar
|
|
29
|
Liu YJ, Xu Y and Yu Q: Full-length
ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic
activity, respectively. Oncogene. 25:2452–2467. 2006. View Article : Google Scholar
|
|
30
|
Tyan SW, Hsu CH, Peng KL, et al: Breast
cancer cells induce stromal fibroblasts to secrete ADAMTS1 for
cancer invasion through an epigenetic change. PLoS One.
7:e351282012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ricciardelli C, Frewin KM, Tan IA, et al:
The ADAMTS1 protease gene is required for mammary tumor growth and
metastasis. Am J Pathol. 179:3075–3085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kohno T, Otsuka A, Girard L, et al: A
catalog of genes homozygously deleted in human lung cancer and the
candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes
Cancer. 49:342–352. 2010.PubMed/NCBI
|
|
33
|
Yegnasubramanian S, Wu Z, Haffner MC, et
al: Chromosome-wide mapping of DNA methylation patterns in normal
and malignant prostate cells reveals pervasive methylation of
gene-associated and conserved intergenic sequences. BMC Genomics.
12:3132011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lind GE, Kleivi K, Meling GI, et al:
ADAMTS1, CRABP1 and NR3C1 identified as epigenetically deregulated
genes in colorectal tumorigenesis. Cell Oncol. 28:259–272.
2006.
|
|
35
|
Li Z, Zhang W, Shao Y, et al:
High-resolution melting analysis of ADAMTS18 methylation levels in
gastric, colorectal and pancreatic cancers. Med Oncol. 27:998–1004.
2010. View Article : Google Scholar
|
|
36
|
Zhang C, Shao Y, Zhang W, et al:
High-resolution melting analysis of ADAMTS9 methylation levels in
gastric, colorectal and pancreatic cancers. Cancer Genet Cytogenet.
196:38–44. 2010. View Article : Google Scholar
|
|
37
|
Singh KP, Treas J, Tyagi T and Gao W: DNA
demethylation by 5-aza-2-deoxycytidine treatment abrogates 17
beta-estradiol-induced cell growth and restores expression of DNA
repair genes in human breast cancer cells. Cancer Lett. 316:62–69.
2012. View Article : Google Scholar
|
